Skip NavigationSkip to Content

Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domain

  1. Author:
    Zhao, X. Z.
    Hymel, D.
    Burke, T. R.
  2. Author Address

    Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States. Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States. Electronic address: burkete@helix.nih.gov.
    1. Year: 2016
    2. Date: 15-Oct
    3. Epub Date: 9/15/2016
  1. Journal: Bioorganic & Medicinal Chemistry Letters
    1. 26
    2. 20
    3. Pages: 5009-5012
  2. Type of Article: Article
  3. ISSN: 0960-894X (Print) 0960-894x
  1. Abstract:

    By a process involving initial screening of a set of 87 aldehydes using an oxime ligation-based strategy, we were able to achieve a several-fold affinity enhancement over one of the most potent previously known polo-like kinase 1 (Plk1) polo-box domain (PBD) binding inhibitors. This improved binding may result by accessing a newly identified auxiliary region proximal to a key hydrophobic cryptic pocket on the surface of the protein. Our findings could have general applicability to the design of PBD-binding antagonists.

    See More

External Sources

  1. DOI: 10.1016/j.bmcl.2016.08.098
  2. PMID: 27624074
  3. PMCID: PMC5061138
  4. WOS: 000385498500031
  5. NIHMSID: NIHMS816092

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel